|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng H and Min J: Role of long noncoding
RNA HOTAIR in the growth and apoptosis of osteosarcoma cell MG-63.
Biomed Res Int. 2016:57576412016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Angiero F, Moltrasio F, Cattoretti G and
Valente MG: Clinical and histopathological profile of primary or
secondary osteosarcoma of the jaws. Anticancer Res. 31:4485–4489.
2011.PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Desandes E: Survival from adolescent
cancer. Cancer Treat Rev. 33:609–615. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maeda Y, Farina NH, Matzelle MM, Fanning
PJ, Lian JB and Gravallese EM: Synovium-derived MicroRNAs regulate
bone pathways in rheumatoid arthritis. J Bone Miner Res.
32:461–472. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S
and Cong N: MicroRNA-98 acts as a tumor suppressor in
hepatocellular carcinoma via targeting SALL4. Oncotarget.
7:74059–74073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi E, Choi E and Hwang KC: MicroRNAs as
novel regulators of stem cell fate. World J Stem Cells. 5:172–187.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hou YY, Lee JH, Chen HC, Yang CM, Huang
SJ, Liou HH, Chi CC, Tsai KW and Ger LP: The association between
miR-499a polymorphism and oral squamous cell carcinoma progression.
Oral Dis. 21:195–206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao M, Zhang H, Zhu G, Liang J, Chen N,
Yang Y, Liang X, Cai H and Liu W: Association between
overexpression of Wip1 and prognosis of patients with non-small
cell lung cancer. Oncol Lett. 11:2365–2370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin S, Wang P, Yang L, Liu Y, Wang Y, Liu
M, Qi Z, Meng J, Shi TY, Yang G and Zang R: Wip1 suppresses ovarian
cancer metastasis through the ATM/AKT/Snail mediated signaling.
Oncotarget. 7:29359–29370. 2016.PubMed/NCBI
|
|
13
|
Zhang X, Wan G, Mlotshwa S, Vance V,
Berger FG, Chen H and Lu X: Oncogenic Wip1 phosphatase is inhibited
by miR-16 in the DNA damage signaling pathway. Cancer Res.
70:7176–7186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Qi L, Han W, Wan X, Jiang S, Li Y,
Xie Y, Liu L, Zeng F, Liu Z and Zu X: Overexpression of wip1 is
associated with biologic behavior in human clear cell renal cell
carcinoma. PLoS One. 9:e1102182014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deng J, Zhang R, Pan Y, Wang B, Wu L, Jiao
X, Bao T, Hao X and Liang H: Comparison of the staging of regional
lymph nodes using the sixth and seventh editions of the
tumor-node-metastasis (TNM) classification system for the
evaluation of overall survival in gastric cancer patients: Findings
of a case-control analysis involving a single institution in China.
Surgery. 156:64–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dang X, Ma A, Yang L, Hu H, Zhu B, Shang
D, Chen T and Luo Y: MicroRNA-26a regulates tumorigenic properties
of EZH2 in human lung carcinoma cells. Cancer Genet. 205:113–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi P, Cheng SQ, Wang H, Li N, Chen YF and
Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma
in Chinese patients with chronic hepatitis B virus infection. PLoS
One. 6:e284862011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shao XJ, Miao MH, Xue J, Xue J, Ji XQ and
Zhu H: The down-regulation of MicroRNA-497 contributes to cell
growth and cisplatin resistance through PI3K/Akt pathway in
osteosarcoma. Cell Physiol Biochem. 36:2051–2062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Wang Y, Xu T, Li C, Wu J, He Q,
Wang G, Ding C, Liu K, Tang H and Ji F: Increased expression of
microRNA-148a in osteosarcoma promotes cancer cell growth by
targeting PTEN. Oncol Lett. 12:3208–3214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang
H, Bi Z and Yang C: MicroRNA-224 promotes the sensitivity of
osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med.
20:1611–1619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu F, Li CB, Yuan BT, Qi W, Li HL, Shen
XZ, Zhao G, Wang JT and Liu YJ: MicroRNA-26a induces osteosarcoma
cell growth and metastasis via the Wnt/β-catenin pathway. Oncol
Lett. 11:1592–1596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang K, Zhang Y, Ren K, Zhao G, Yan K and
Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by
downregulation of EZH2 expression. Oncol Rep. 32:2143–2149. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun XH, Geng XL, Zhang J and Zhang C:
miRNA-646 suppresses osteosarcoma cell metastasis by downregulating
fibroblast growth factor 2 (FGF2). Tumour Biol. 36:2127–2134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li E, Zhang J, Yuan T and Ma B: MiR-145
inhibits osteosarcoma cells proliferation and invasion by targeting
ROCK1. Tumour Biol. 35:7645–7650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao D, Jia P, Wang W and Zhang G:
VEGF-mediated suppression of cell proliferation and invasion by
miR-410 in osteosarcoma. Mol Cell Biochem. 400:87–95. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ruan WD, Wang P, Feng S, Xue Y and Zhang
B: MicroRNA-497 inhibits cell proliferation, migration, and
invasion by targeting AMOT in human osteosarcoma cells. Onco
Targets Ther. 9:303–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Yang Y, Peng Y, Austin RJ, van
Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey
T, et al: Oncogenic properties of PPM1D located within a breast
cancer amplification epicenter at 17q23. Nat Genet. 31:133–134.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirasawa A, Saito-Ohara F, Inoue J, Aoki
D, Susumu N, Yokoyama T, Nozawa S, Inazawa J and Imoto I:
Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas
with poor prognosis and identification of PPM1D and APPBP2 as
likely amplification targets. Clin Cancer Res. 9:1995–2004.
2003.PubMed/NCBI
|
|
30
|
Loukopoulos P, Shibata T, Katoh H, Kokubu
A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, et
al: Genome-wide array-based comparative genomic hybridization
analysis of pancreatic adenocarcinoma: Identification of genetic
indicators that predict patient outcome. Cancer Sci. 98:392–400.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ehrbrecht A, Müller U, Wolter M, Hoischen
A, Koch A, Radlwimmer B, Actor B, Mincheva A, Pietsch T, Lichter P,
et al: Comprehensive genomic analysis of desmoplastic
medulloblastomas: Identification of novel amplified genes and
separate evaluation of the different histological components. J
Pathol. 208:554–563. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fuku T, Semba S, Yutori H and Yokozaki H:
Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D)
expression correlated with downregulation of checkpoint kinase 2 in
human gastric carcinoma. Pathol Int. 57:566–571. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun B, Hu X, Liu G, Ma B, Xu Y, Yang T,
Shi J, Yang F, Li H, Zhang L and Zhao Y: Phosphatase Wip1
negatively regulates neutrophil migration and inflammation. J
Immunol. 192:1184–1195. 2014. View Article : Google Scholar : PubMed/NCBI
|
